NCT02876159View on ClinicalTrials.gov

The Immunologic Basis for an Attenuated Immune Response to the Influenza Vaccine After Repeated Annual Vaccination

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

October 18, 2016

Study Completion Date

December 1, 2016

Conditions
Influenza
Interventions
BIOLOGICAL

2016-2017 Influenza Vaccine

Quadrivalent influenza A/Hemagglutinin Type 1 (H1N1), A/Influenza A virus subtype (A/H3N2) H3N2,and B virus vaccine for Intramuscular (IM) use is a sterile, clear and slightly opalescent suspension administered as a single 0.5 mL intramuscular dose.

Trial Locations (1)

30322

The Hope Clinic of the Emory Vaccine Center, Atlanta

All Listed Sponsors
lead

Emory University

OTHER

NCT02876159 - The Immunologic Basis for an Attenuated Immune Response to the Influenza Vaccine After Repeated Annual Vaccination | Biotech Hunter | Biotech Hunter